Health

Results: 457-468 of 9490

Innovative Molecules Announces First Patient Dosed in Phase 2a Trial of Adibelivir (IM-250), Advancing Company into Late-Stage Clinical Development

H.B. Fuller Announces Offer to Acquire Advanced Medical Solutions

PR Newswire associated0

Circulate Health announces exclusive partnership with Reborne to bring its advanced therapeutic plasma exchange protocols to UK for first time

PR Newswire associated0

Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region

PR Newswire associated0

Proliant Health & Biologicals Raises the Albumin Standard with AlbufreeDX: Consistent, Animal-Free Recombinant Human Albumin

ZINZINO AB (PUBL.): SHARE SUBSCRIPTION THROUGH A DIRECTED SET-OFF ISSUE

PR Newswire associated0

REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stem Cell Therapy Stemchymal® for Spinocerebellar Ataxia (SCA3 and SCA6)

StatLab Launches CytoPath Disc, Advancing Standardized Cell Block Preparation Worldwide

PR Newswire associated0

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

Carnegie Mellon University is leading a multi-university team that has secured an award of up to $39.3 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop a wearable monitoring system to better identify fetal distress and its cause, enabling a safer labor and delivery experience for mothers and babies.

Carnegie Mellon Team Awarded ARPA-H Contract to Transform Care During Labor and Childbirth

Welcome to the Superaging Era: Youth is no Longer the Holy Grail as Gen X and Millennials Chase the 100-Year Lifestyle